Tyme Technologies, Inc. (TYME): Price and Financial Metrics
TYME Price/Volume Stats
| Current price | $0.31 | 52-week high | $1.14 |
| Prev. close | $0.29 | 52-week low | $0.22 |
| Day low | $0.29 | Volume | 2,678,100 |
| Day high | $0.32 | Avg. volume | 1,009,732 |
| 50-day MA | $0.30 | Dividend yield | N/A |
| 200-day MA | $0.37 | Market Cap | 53.50M |
TYME Stock Price Chart Interactive Chart >
Tyme Technologies, Inc. (TYME) Company Bio
Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications. It is developing SM-88, a combination therapy in Phase II development for prostate cancer. The company was founded in 2011 and is based in New York, New York.
TYME Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -61.07% |
| 5-year | -73.73% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -50.57% |
| 2020 | -12.86% |
| 2019 | -62.06% |
Loading social stream, please wait...